Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

N Harry

Showing results (31-40 of 98) with videos related to

Pageof 10
Sort By:
Clinical Nuclear Medicine|July 24, 2023
The Influence of Long-Acting Somatostatin Analogs on 68 Ga-DOTATATE Uptake in Patients With Neuroendocrine TumorsYoussef Chahid, Khaled Hashimi, Ewoudt M W van de Garde, et al.
European Journal of Clinical Pharmacology|February 8, 2019
Feasibility of and patients' perspective on nilotinib dried blood spot self-samplingChristel C L M Boons, Lonneke Timmers, Jeroen J W M Janssen, et al.
Annals of Neurology|January 26, 2005
Blood-brain barrier dysfunction in parkinsonian midbrain in vivoRudie Kortekaas, Klaus L Leenders, Joost C H van Oostrom, et al.
The International Journal of Neuropsychopharmacology|February 20, 2009
Locally increased P-glycoprotein function in major depression: a PET study with [11C]verapamil as a probe for P-glycoprotein function in the blood-brain barrierOnno L de Klerk, Antoon T M Willemsen, Meyke Roosink, et al.
Cellular Oncology (Dordrecht, Netherlands)|September 25, 2014
Molecular imaging of targeted therapies with positron emission tomography: the visualization of personalized cancer careLemonitsa H Mammatas, Henk M W Verheul, N Harry Hendrikse, et al.
Seizure|May 22, 2024
Tolerability of tariquidar - A third generation P-gp inhibitor as add-on medication to antiseizure medications in drug-resistant epilepsyMaria Ilyas-Feldmann, Oliver Langer, Martin Bauer, et al.
The Quarterly Journal of Nuclear Medicine and Molecular Imaging : Official Publication of the Italian Association of Nuclear Medicine (AIMN) [And] the International Association of Radiopharmacology (IAR), [And] Section of the Society Of|December 18, 2014
89Zr-immuno-PET for imaging of long circulating drugs and disease targets: why, how and when to be applied?G A Van Dongen, M C Huisman, R Boellaard, et al.
Psychiatry Research|July 13, 2010
Regional increase in P-glycoprotein function in the blood-brain barrier of patients with chronic schizophrenia: a PET study with [(11)C]verapamil as a probe for P-glycoprotein functionOnno L de Klerk, Antoon T M Willemsen, Fokko J Bosker, et al.
Frontiers in Oncology|November 23, 2017
Effective Drug Delivery in Diffuse Intrinsic Pontine Glioma: A Theoretical Model to Identify Potential CandidatesFatma E El-Khouly, Dannis G van Vuurden, Thom Stroink, et al.
Cancer Medicine|November 24, 2017
Patient satisfaction with information on oral anticancer agent useChristel C L M Boons, Lonneke Timmers, Natasja M van Schoor, et al.
Pageof 10

Showing results (31-40 of 98) with videos related to

Sort By:
Pageof 10
Clinical Nuclear Medicine|July 24, 2023
The Influence of Long-Acting Somatostatin Analogs on 68 Ga-DOTATATE Uptake in Patients With Neuroendocrine TumorsYoussef Chahid, Khaled Hashimi, Ewoudt M W van de Garde, et al.
European Journal of Clinical Pharmacology|February 8, 2019
Feasibility of and patients' perspective on nilotinib dried blood spot self-samplingChristel C L M Boons, Lonneke Timmers, Jeroen J W M Janssen, et al.
Annals of Neurology|January 26, 2005
Blood-brain barrier dysfunction in parkinsonian midbrain in vivoRudie Kortekaas, Klaus L Leenders, Joost C H van Oostrom, et al.
The International Journal of Neuropsychopharmacology|February 20, 2009
Locally increased P-glycoprotein function in major depression: a PET study with [11C]verapamil as a probe for P-glycoprotein function in the blood-brain barrierOnno L de Klerk, Antoon T M Willemsen, Meyke Roosink, et al.
Cellular Oncology (Dordrecht, Netherlands)|September 25, 2014
Molecular imaging of targeted therapies with positron emission tomography: the visualization of personalized cancer careLemonitsa H Mammatas, Henk M W Verheul, N Harry Hendrikse, et al.
Seizure|May 22, 2024
Tolerability of tariquidar - A third generation P-gp inhibitor as add-on medication to antiseizure medications in drug-resistant epilepsyMaria Ilyas-Feldmann, Oliver Langer, Martin Bauer, et al.
The Quarterly Journal of Nuclear Medicine and Molecular Imaging : Official Publication of the Italian Association of Nuclear Medicine (AIMN) [And] the International Association of Radiopharmacology (IAR), [And] Section of the Society Of|December 18, 2014
89Zr-immuno-PET for imaging of long circulating drugs and disease targets: why, how and when to be applied?G A Van Dongen, M C Huisman, R Boellaard, et al.
Psychiatry Research|July 13, 2010
Regional increase in P-glycoprotein function in the blood-brain barrier of patients with chronic schizophrenia: a PET study with [(11)C]verapamil as a probe for P-glycoprotein functionOnno L de Klerk, Antoon T M Willemsen, Fokko J Bosker, et al.
Frontiers in Oncology|November 23, 2017
Effective Drug Delivery in Diffuse Intrinsic Pontine Glioma: A Theoretical Model to Identify Potential CandidatesFatma E El-Khouly, Dannis G van Vuurden, Thom Stroink, et al.
Cancer Medicine|November 24, 2017
Patient satisfaction with information on oral anticancer agent useChristel C L M Boons, Lonneke Timmers, Natasja M van Schoor, et al.
Pageof 10